Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cemtrex (CETXP) EBT (2016 - 2025)

Cemtrex filings provide 16 years of EBT readings, the most recent being -$20.3 million for Q4 2025.

  • On a quarterly basis, EBT rose 28.81% to -$20.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$20.1 million, a 27.31% increase, with the full-year FY2025 number at -$28.4 million, down 7248.31% from a year prior.
  • EBT hit -$20.3 million in Q4 2025 for Cemtrex, down from -$3.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $11.4 million in Q3 2024 to a low of -$28.5 million in Q4 2024.
  • Median EBT over the past 5 years was -$1.2 million (2021), compared with a mean of -$2.4 million.
  • Biggest five-year swings in EBT: plummeted 2195.41% in 2024 and later skyrocketed 689.19% in 2025.
  • Cemtrex's EBT stood at -$3.8 million in 2021, then rose by 17.88% to -$3.1 million in 2022, then surged by 59.84% to -$1.2 million in 2023, then plummeted by 2195.41% to -$28.5 million in 2024, then grew by 28.81% to -$20.3 million in 2025.
  • The last three reported values for EBT were -$20.3 million (Q4 2025), -$3.9 million (Q3 2025), and -$4.6 million (Q2 2025) per Business Quant data.